The Mucosal Immunology Core Laboratory (MICL) was first proposed and funded in 1998 due to anemerging awareness that mucosal lymphoid tissues were critically important as a reservoir for HIV infection.To our knowledge, this was the first Core facility of its kind in CFAR and continues to be a unique resourcenationally. Interested researchers had little access to freshly acquired tissue and there were no validatedassays for quantifying tissue HIV viral burden as well as other relevant mucosal immunologic and virologicmarkers. Since the start of the most recent CFAR renewal 4.5 years ago, the MICL has collected over 8000mucosal tissue biopsies for study from 362 subjects. An additional 407 MICL encounters include 235 subjectvisits for screening, blood or semen donation without biopsies and 172 tissue specimens received fromcollaborators for assays or tissue specimens received from the Tissue Procurement Core Laboratory(TPCL). Also the MICL has supported 21 researchers (8 non-UCLA), 21 grant applications (16 funded), andduring the past 2 years the MICL has developed a Clinical Trial Registry of 317 potential subjects forproactive recruitment as needed. This resource in unmatched anywhere and is a very unique CFARresource for HIV investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI028697-19
Application #
7480739
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2008-05-15
Project End
2013-02-28
Budget Start
2008-05-15
Budget End
2009-02-28
Support Year
19
Fiscal Year
2008
Total Cost
$60,500
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Allyn, P R; O'Malley, S M; Ferguson, J et al. (2018) Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection. Int J STD AIDS 29:334-340
Khamaikawin, Wannisa; Shimizu, Saki; Kamata, Masakazu et al. (2018) Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Mol Ther Methods Clin Dev 9:23-32
Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2018) Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight 3:
Gorbach, Pamina M; Javanbakht, Marjan; Bolan, Robert K (2018) Behavior change following HIV diagnosis: findings from a Cohort of Los Angeles MSM. AIDS Care 30:300-304
Rotheram-Borus, Mary Jane; Davis, Emily; Rezai, Roxana (2018) Stopping the rise of HIV among adolescents globally. Curr Opin Pediatr 30:131-136
Allan-Blitz, Lao-Tzu; Sakona, Ashyln; Wallace, William D et al. (2018) Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017. Emerg Infect Dis 24:
Kojima, Noah; Klausner, Jeffrey D (2018) An Update on the Global Epidemiology of Syphilis. Curr Epidemiol Rep 5:24-38
Nakatsuka, Nako; Hasani-Sadrabadi, Mohammad Mahdi; Cheung, Kevin M et al. (2018) Polyserotonin Nanoparticles as Multifunctional Materials for Biomedical Applications. ACS Nano 12:4761-4774
Cisneros, Irma E; Erdenizmenli, Mert; Cunningham, Kathryn A et al. (2018) Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 135:431-443
Marsden, Matthew D; Wu, Xiaomeng; Navab, Sara M et al. (2018) Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents. Virology 520:83-93

Showing the most recent 10 out of 942 publications